CAI
CAI
NASDAQ · Biotechnology

Caris Life Sciences Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$17.60
+0.29 (+1.68%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 14 88%
Hold 2 13%
Sell 0 0%
Price Target
Analyst Price Target +75.7% upside
Low Target $20.23
Average Target $30.92
High Target $48.05
Current Price $17.60
Current
$17.60
Target
$30.92
$20.23 $30.92 avg $48.05
Scenario Analysis
Bear Case
$20.23
14.9%
Low target
Base Case
$30.92
+75.7%
Avg target
Bull Case
$48.05
+173.0%
High target
Risk/Reward
11.6x
Highly favorable
Price in Context
52-Week High
$42.50
-58.6% from high
52-Week Low
$14.19
+24.0% from low
50-Day SMA
$25.57
-31.2% vs SMA
RSI (14)
21.6
Oversold
Target vs 52W High
$30.92
-27.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%